Skip to main content
logo
AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden flag Sweden · Delayed Price · Currency is SEK
6.72
0.00 (0.00%)
Aug 13, 2026, 5:29 PM CET

AlzeCure Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
927230102182242216
Market Cap Growth
174.74%126.34%-44.24%-24.88%12.31%-34.33%
Enterprise Value
896182.0573.68153216.83174.11
Last Close Price
6.722.001.152.933.905.72

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-7.337.332.35--
PB Ratio
82.556.983.897.664.016.55
P/TBV Ratio
64.246.113.417.673.106.62
P/FCF Ratio
---59.57--
P/OCF Ratio
---59.57--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/FCF Ratio
---50.05--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.200.080.14000
Net Debt / Equity Ratio
-2.73-1.45-1.07-1.22-0.42-1.27
Net Debt / EBITDA Ratio
0.831.020.810.770.460.54
Net Debt / FCF Ratio
0.741.380.81-9.520.260.59
Quick Ratio
1.302.283.493.722.603.42
Current Ratio
1.362.333.553.842.663.49
Return on Equity (ROE)
-169.94%-161.56%-141.83%-88.22%-120.35%-108.23%
Return on Assets (ROA)
-75.61%-97.41%-100.85%-74.41%-96.91%-95.34%
Return on Invested Capital (ROIC)
----258.71%-431.88%-
Return on Capital Employed (ROCE)
-154.07%-146.94%-134.48%-90.82%-120.79%-108.43%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
FCF Yield
---1.68%--
Buyback Yield / Dilution
-28.01%-30.26%-24.26%-29.21%-25.87%-0.33%
Total Shareholder Return
-28.01%-30.26%-24.26%-29.21%-25.87%-0.33%